Skip to content

Dynamic Congruence Total Knee Replacement vs Posterior-stabilized

Does Dynamic Congruence Design Improve Gait After Total Knee Replacement in Comparison to Posterior-stabilized One? - Prospective Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04524312
Acronym
K-Mod
Enrollment
56
Registered
2020-08-24
Start date
2017-12-01
Completion date
2020-09-26
Last updated
2020-09-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Joint Diseases, Osteo Arthritis Knee, Surgery

Keywords

osteoarthritis, knee, congruence, posterior-stabilized, cruciate-retaining

Brief summary

This study compares and evaluates differences in movement analysis, patient-reported outcome between patients undergoing total knee arthroplasty with use of either Zimmer Biomet NexGen with posterior stabilization and Bioimplanti K-Mod cruciate-retaining with dynamic congruence

Detailed description

The aim of this study is to assess and compare kinematic and time-space gait parameters in patients after total knee arthroplasty, who will undergo the surgery with the use of either posterior-stabilized (PS) or dynamic congruence (DC) implants. Materials and methods To this study 56 consecutive patients undergoing total knee arthroplasty will be recruited. Study protocol is designed as a prospective, blinded, parallel-group, superiority trial, with balanced randomization \[1:1\]. All participants will be operated in single clinical orthopedic department, by single high-volume surgeon, who performed more than 3000 total knee arthroplasties in his professional career. Before the surgery patients will fulfill the author's questionnaire concerning their age, height and body mass, level of activity and VAS (Visual Analogue Scale). After the surgery 1 to 3 years postoperatively three-dimensional gait analysis will performed with use of BTS SMART device. This device uses passive markers technology and registers the movement by six cameras. To perform full gait analysis several data concerning patients anthropometry will be collected (lower limb length, knee and ankle joint width, width and depth of the pelvis). Whole gait analysis will be performed by experienced single clinical biomechanist accordingly to the Davis protocol. Markers will be installed on the patients' limbs on the following points: base of sacral bone, greater trochanter of the femur, lateral femoral condyle, head of the fibula, lateral malleoli, head of the V metatarsal bone). Participants will walk barefoot for 10 meters quadruple times. Following time-space and kinematic parameters will be assessed: Time-space parameters Single stance time (T1) \[%\] Swing time (T2) \[%\] Double-stance time (T3) \[%\] Step length (SL) \[m\] Mean gait velocity (Vm) \[m/s\] Cadence (C) \[number of steps/min\] Kinematic parameters: Operated knee range of flexion during swing phase \[°\]

Interventions

PROCEDURETotal knee replacement

Participant will undergo total knee replacement performed via anterior parapatellar approach with either Posterior-stabilized or retaining cruciate-retaining with dynamic congruence implant

DIAGNOSTIC_TESTBiomechanics

Participants will be asked to perform biomechanical assesment before and following surgery at baseline, 6-8 weeks and 6-months postoperatively

DEVICENexGen Ps or Bioimplanti K-MOD implant

Participant are randomly allocated to receive one of the NexGen PS or Biomplanti K-MOD total knee implant for treatment of end-stage knee osteoarthritis.

Sponsors

Medical University of Warsaw
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Masking description

Participant will not be informed which type of prosthesis was used in their particular case. Outcomes Assessor will not be informed which type of prosthesis was used in particular patient.

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* agreement to participate in the study * BMI (kg/m2) less than 40 * ability to walk for 10 meters * knee flexion more or equal of 90 degrees

Exclusion criteria

* unwillingness to participate in the study * osteoarthritis due to the rheumatological disease * disorders associated with nerve-muscle signal transmission * neurological disorders associated with dizziness, nystagmus or other conditions that might influence balance during activity

Design outcomes

Primary

MeasureTime frameDescription
Time of swing phaseTime Frame: 1-3 years after surgeryChange from baseline part of swing phase time during gait, measured in percentage Change from baseline part of swing phase time during gait, measured in percentage
Time of stance phaseTime Frame: 1-3 years after surgeryChange from baseline part of stance phase time during gait, measured in percentage
Time of double-stance phaseTime Frame: 1-3 years after surgeryChange from baseline part of double-stance phase time during gait, measured in percentage
Stride lengthTime Frame: 1-3 years after surgeryChange from baseline length of stride during gait, measured in meters
CadenceTime Frame: 1-3 years after surgeryChange from baseline number of strides per minute of walking
Mean gait velocityTime Frame: 1-3 years after surgeryChange from baseline mean values of gait speed, measured in meters per second
Range of maximal hip extension for both limbs during ending part of mid-stance phaseTime Frame: 1-3 years after surgeryChange from baseline range of maximal hip extension for both limbs during ending part of mid-stance phase, measured in degrees
Range of pelvic drop in frontal plane on the opposite site of the bearing limbTime Frame: 1-3 years after surgeryChange from baseline range of pelvic drop in frontal plane on the opposite site of the bearing limb, measured in degrees

Countries

Poland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026